Pleasanton, Calif.-based Thoratec is getting into the ring with Abiomed (NSDQ:ABMD), preparing its version of a percutaneous heart pump to compete with the Impella device that Abiomed already has on the market, CEO Gary Burbach said at the JP Morgan health care conference this morning.
J.P. Morgan Healthcare Conference
After 7 months on the job, Medtronic CEO Omar Ishrak laid out his vision for transforming the world’s largest pure-play medical device maker today at his first appearance at the J.P. Morgan health care comference in San Francisco.
The Pipeline stroke-treatment device Covidien plc (NYSE:COV) acquired with its $2.6 billion acquisition of ev3 Inc. is gaining share in markets across the globe, CEO Jose Almeida told analysts this morning.
Covidien’s acquisition of ev3 is paying off around the world and is expected to do "slightly better" than originally thought, Almeida told investors at the JP Morgan health care conference in San Francisco today.